Quarkmed
PrivateLast Round
Series A
Oct 11, 2024
Company Overview
Quarkmed is a contract research organization (CRO) that provides comprehensive clinical research services, including clinical trial management, biostatistics, data management, and international regulatory registration for pharmaceutical and medical device companies.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Biotechnology, Medical Devices, Medical Imaging, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Quarkmed Comparables
Compare Quarkmed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GCP ClinPlus | 85% | |
| ClinChoice | 84% | |
| R&G PharmaStudies Co., Ltd. | 80% |
Quarkmed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 11, 2024 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2026
Monthly visitors increased 119% MoM, reaching 3.6K.
- Oct 11, 2024
Completed a Series A funding round.
Quarkmed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Quarkmed's valuation, stock price, and market status.
Is Quarkmed a public or private company?
Quarkmed is a private company.
What is the current stock price of Quarkmed?
Quarkmed is a private company with no public stock price. No recent secondary market data is available.
How much is Quarkmed worth (valuation)?
Valuation information for Quarkmed is not publicly available.
Can I buy Quarkmed stock?
Quarkmed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Quarkmed's last funding round?
Quarkmed's most recent funding round was Series A on October 11, 2024.
Who are the main investors in Quarkmed?
Investor information for Quarkmed is not publicly disclosed.
Will Quarkmed IPO soon?
No public IPO plans have been announced for Quarkmed.
How can I track Quarkmed secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Quarkmed's secondary market activity and sign up for updates.